Health Informatics Research and Evaluation Unit, Faculty of Health Sciences, The University of Sydney, Sydney, New South Wales, Australia.
Intern Med J. 2012 Jan;42(1):57-64. doi: 10.1111/j.1445-5994.2010.02284.x. Epub 2010 Jun 7.
EviQ is a web-based oncology protocol system launched across Australia in 2005 (http://www.eviq.org.au). We evaluated eviQ use at the point-of-care and determined the factors impacting on its uptake and routine use in the first three years of operation.
We conducted a suite of qualitative and quantitative studies with over 200 Australian oncology physicians, nurses and pharmacists working at treatment centres in diverse geographical locations.
EviQ was part of routine care at many hospitals; however, the way in which it was used at the point-of-care varies according to clinician roles and hospital location. We identified a range of factors impacting on eviQ uptake and routine use. Infrastructure, such as availability of point-of-care computers, and formal policies endorsing eviQ are fundamental to increasing uptake. Furthermore, the level of clinical and computer experience of end-users, the attitudes and behaviour of clinicians, endorsement and promotion strategies, and level and type of eviQ education all need to be considered and managed to ensure that the system is being used to its full potential.
Our findings show that the dissemination of web-based treatment protocols does not guarantee widespread use. Organisational, environmental and clinician-specific factors play a role in uptake and utilisation. The deployment of sufficient computer infrastructure, implementation of targeted training programmes and hospital policies and investment in marketing approaches are fundamental to uptake and continued use. This study highlights the value of ongoing monitoring and evaluation to ensure systems like eviQ achieve their primary purpose - reducing treatment variation and improving quality of care.
EviQ 是一个基于网络的肿瘤学方案系统,于 2005 年在澳大利亚推出(http://www.eviq.org.au)。我们在护理点评估了 eviQ 的使用情况,并确定了在运营的头三年中影响其采用和常规使用的因素。
我们对 200 多名在不同地理位置的治疗中心工作的澳大利亚肿瘤医生、护士和药剂师进行了一系列定性和定量研究。
EviQ 在许多医院都是常规护理的一部分;然而,它在护理点的使用方式因临床医生的角色和医院的位置而异。我们确定了一系列影响 eviQ 采用和常规使用的因素。基础设施,如护理点计算机的可用性,以及支持 eviQ 的正式政策,是增加采用率的基础。此外,最终用户的临床和计算机经验水平、临床医生的态度和行为、认可和推广策略,以及 eviQ 教育的水平和类型都需要考虑和管理,以确保系统能够充分发挥其潜力。
我们的研究结果表明,基于网络的治疗方案的传播并不能保证广泛使用。组织、环境和临床医生特定的因素在采用和利用方面发挥作用。部署足够的计算机基础设施、实施有针对性的培训计划和医院政策以及投资营销方法是采用和持续使用的基础。本研究强调了持续监测和评估的价值,以确保像 eviQ 这样的系统实现其主要目的-减少治疗差异,提高护理质量。